A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer

A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer

Moores Cancer Center, UC San Diego Health

La Jolla, California, United States, 92093

Contact: Shakeela Dad         

Principal Investigator: Rebekah White, MD         

University of Florida Health

Gainesville, Florida, United States, 32608

Contact: Sean Wiley         

Principal Investigator: Robert Heithaus, MD         

Mayo Clinic, Jacksonville

Jacksonville, Florida, United States, 32224

Contact: Mauricia Buchanan         

Principal Investigator: John Stauffer, MD         

Miami Cancer Institute

Miami, Florida, United States, 33176

Contact: Ernesto Cue Barroso         

Principal Investigator: Govindarajan Narayanan, MD         

University of South Florida

Tampa, Florida, United States, 33620

Contact: Thanh Tran         

Principal Investigator: Vic Velanovich, MD         

Wellstar Medical Group

Marietta, Georgia, United States, 30060

Contact: Holly Holtzclaw         

Principal Investigator: Sartaj Sanghera, MD         

Northwest Community Hospital

Arlington Heights, Illinois, United States, 60005

Contact: Karen Zwicky         

Principal Investigator: Malcolm M Bilimoria, MD         

University of Iowa Healthcare

Iowa City, Iowa, United States, 52242

Contact: Laura Jacobus         

Principal Investigator: Carlos Chan, MD         

Norton Healthcare

Louisville, Kentucky, United States, 40202

Contact: Mary Healey         

Principal Investigator: Robert Martin, MD, PhD, FACS         

Mercy Medical Center

Baltimore, Maryland, United States, 21202

Contact: Lisa McConnell         

Principal Investigator: Debashish Bose, MD         

Mayo Clinic, Rochester

Rochester, Minnesota, United States, 55905

Contact: Danielle Patnode         

Principal Investigator: Sean Cleary, MD         

University of Mississippi

Jackson, Mississippi, United States, 39216

Contact: Leila Seidfaraji         

Principal Investigator: Truman Earl, MD         

Barnes-Jewish Hospital

Saint Louis, Missouri, United States, 63110

Contact: Marvin Petty         

Principal Investigator: Chet Hammill, MD         

Capital Health

Trenton, New Jersey, United States, 08638

Contact: Soroya Sanchez Molero         

Principal Investigator: Cataldo Doria, MD         

NYU Langone

New York, New York, United States, 10016

Contact: Xiaohong Jing         

Principal Investigator: Theodore Welling, MD         

Presbyterian Hospital, Columbia

New York, New York, United States, 10032

Contact: Susie Flores         

Principal Investigator: Michael Kluger, MD         

Atrium Health

Charlotte, North Carolina, United States, 28204

Contact: Hiral Amin         

Principal Investigator: David Iannitti, MD         

St. Luke’s University Health Network

Easton, Pennsylvania, United States, 18045

Contact: Elana Pessin         

Principal Investigator: Darius Desai, MD         

University of Texas-Southwestern

Dallas, Texas, United States, 75231

Contact: Misbah Shabbir         

Principal Investigator: Patricio Polanco, MD         

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 26, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine